OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2022) Vol. 934, pp. 175302-175302
Open Access | Times Cited: 15
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2022) Vol. 934, pp. 175302-175302
Open Access | Times Cited: 15
Showing 15 citing articles:
Targeting epigenetic modifications in Parkinson's disease therapy
Dan Zhang, Jifa Zhang, Yuxi Wang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1748-1777
Closed Access | Times Cited: 16
Dan Zhang, Jifa Zhang, Yuxi Wang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1748-1777
Closed Access | Times Cited: 16
GDNF and miRNA-29a as biomarkers in the first episode of psychosis: uncovering associations with psychosocial factors
Marta Szwajca, Grzegorz Kazek, Natalia Śmierciak, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Marta Szwajca, Grzegorz Kazek, Natalia Śmierciak, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
CircARID1B Promotes MPP+-Induced Death and Inflammation in Dopaminergic Neurons by Elevating MAVS Through Sequestering miR-143-3p
Xuejie Zhang, Xuan Shi, Zhining Liu
Cell Biochemistry and Biophysics (2025)
Closed Access
Xuejie Zhang, Xuan Shi, Zhining Liu
Cell Biochemistry and Biophysics (2025)
Closed Access
Ginsenoside Rg3 Restores Mitochondrial Cardiolipin Homeostasis via GRB2 to Prevent Parkinson's Disease
Li‐Feng‐Rong Qi, Shuai Liu, Qiuyuan Fang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 4
Li‐Feng‐Rong Qi, Shuai Liu, Qiuyuan Fang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 4
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson’s disease
Shengyang Zhou, Ting Li, Wei Zhang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 8, pp. 2361-2372
Open Access | Times Cited: 4
Shengyang Zhou, Ting Li, Wei Zhang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 8, pp. 2361-2372
Open Access | Times Cited: 4
Unraveling the Epigenetic Landscape: Insights into Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis
Pierpaolo Di Martino, Valentina Marcozzi, Sandra Bibbò, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 553-553
Open Access | Times Cited: 3
Pierpaolo Di Martino, Valentina Marcozzi, Sandra Bibbò, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 553-553
Open Access | Times Cited: 3
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Yumei Liu, Kunpeng Qin, Chunyan Jiang, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 3
Yumei Liu, Kunpeng Qin, Chunyan Jiang, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 3
Dataset of miRNA–disease relations extracted from textual data using transformer-based neural networks
Sumit Madan, Lisa Kühnel, Holger Fröhlich, et al.
Database (2024) Vol. 2024
Open Access | Times Cited: 2
Sumit Madan, Lisa Kühnel, Holger Fröhlich, et al.
Database (2024) Vol. 2024
Open Access | Times Cited: 2
MicroRNAs Modulating Neuroinflammation in Parkinson's disease
Mohamed J. Saadh, Faris Anad Muhammad, Anamika Singh, et al.
Inflammation (2024)
Closed Access | Times Cited: 2
Mohamed J. Saadh, Faris Anad Muhammad, Anamika Singh, et al.
Inflammation (2024)
Closed Access | Times Cited: 2
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105206-105206
Closed Access | Times Cited: 4
James S. Brown
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105206-105206
Closed Access | Times Cited: 4
MiR-29a efficiently suppresses the generation of reactive oxygen species and α-synuclein in a cellular model of Parkinson's disease by potentially targeting GSK-3β
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2024) Vol. 974, pp. 176615-176615
Open Access
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2024) Vol. 974, pp. 176615-176615
Open Access
Personalized epigenetics of neurodegenerative diseases
Vipasha Gautam, Arushi Sandhu, Kajal Rawat, et al.
Elsevier eBooks (2024), pp. 565-598
Closed Access
Vipasha Gautam, Arushi Sandhu, Kajal Rawat, et al.
Elsevier eBooks (2024), pp. 565-598
Closed Access
miRNAs As Biomarkers for Neurodegenerative Diseases
Moisés Manuel Gallardo-Pérez, Solón Javier Garcés‐Eisele
Epigenetics and human health (2024), pp. 157-186
Closed Access
Moisés Manuel Gallardo-Pérez, Solón Javier Garcés‐Eisele
Epigenetics and human health (2024), pp. 157-186
Closed Access
Novel therapeutic targets to halt the progression of Parkinson’s disease: an in-depth review on molecular signalling cascades
S. K. Meheronnisha, Dithu Thekkekkara, Amrita Babu, et al.
3 Biotech (2023) Vol. 13, Iss. 7
Open Access
S. K. Meheronnisha, Dithu Thekkekkara, Amrita Babu, et al.
3 Biotech (2023) Vol. 13, Iss. 7
Open Access
